Contamination profiles and mass loadings of macrolide antibiotics and illicit drugs from a small urban wastewater treatment plant

Loganathan, Bommanna G.; Phillips, Malia; Mowery, Holly; Jones-Lepp, Tammy L.

doi:10.1016/j.chemosphere.2008.11.047

Cited by 149 publications

(74 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Overall removals of cocaine, benzoylecgonine and amphetaminetype stimulants were generally in the range of those reported by others even though the latter are known to be very sensitive to different treatment technologies and often exhibit negative removals during treatment (Bijlsma et al, 2012;Boleda et al, 2007;Bones et al, 2007;Loganathan et al, 2009;Metcalfe et al, 2010;Postigo et al, 2008aPostigo et al, ,b, 2010Valcárcel et al, 2012;Yargeau et al, in press). The discrepancies with the removals reported in literature and those observed in this study may be due to various factors such as the type of treatment process used at the treatment plant under investigation (Joss et al, 2006;Kanda et al, 2003), the solids and hydraulic retention times (Clara et al, 2005;Kreuzinger et al, 2004;Tauxe-Wuersch et al, 2005), the dilution of influent wastewater by rain events during the sampling period (Joss et al, 2006;Tauxe-Wuersch et al, 2005;Ternes, 1998) and very likely by the calculation used to obtain the removals themselves.…”

Section: Removal Of Doas By Wastewater Treatmentmentioning

confidence: 59%

Impact of approach used to determine removal levels of drugs of abuse during wastewater treatment

Rodayan

Majewsky

Yargeau

2014

Science of The Total Environment

View full text Add to dashboard Cite

• 19 drugs of abuse were studied throughout a wastewater treatment plant.• Drug levels were generally comparable between composite, POCIS and grab samples.• Overall drug removals during wastewater treatment varied between −84 and 90%.• Time-shifted mass balancing eliminated negative removals obtained with other approaches. In this study the levels of 19 drugs of abuse were estimated throughout a wastewater treatment plant using polar organic chemical integrative samplers (POCIS), 24 h composite samples and grab samples. Overall removal efficiencies and removals in between each treatment unit were calculated using load data for each sampling technique as well as removals that take into account the hydraulic residence time distribution of the treatment plant (time-shifted mass balancing approach). Amphetamine-type stimulants, cocaine and its major metabolite, benzoylecgonine and opioid levels determined with 24 h composite samples were generally comparable to those obtained with POCIS and grab samples. Negative mass balances resulting from the estimation of overall removal efficiencies by POCIS, day-to-day mass balancing of 24 h composite and grab sample data did not occur when the hydraulic retention time (HRT) distributions of the plant were taken into account for calculation. Among the compounds investigated, cocaine exhibited the highest overall removal (90%) while codeine had the lowest with 13%, respectively. Sampling between the treatment units revealed that highest removal occurs during biological treatment as compared to primary or secondary clarification. Methylenedioxyamphetamine (MDA), fentanyl, dihydrocodeine and heroin were not detected in wastewater at any of the sampling locations at the treatment plant regardless of the sampling technique. The study demonstrates the benefits of applying the time-shifted mass balancing approach to the calculation of removals of drugs of abuse during wastewater treatment. a b s t r a c t a r t i c l e i n f o

show abstract

Section: Removal Of Doas By Wastewater Treatmentmentioning

confidence: 59%

Impact of approach used to determine removal levels of drugs of abuse during wastewater treatment

Rodayan

Majewsky

Yargeau

2014

Science of The Total Environment

View full text Add to dashboard Cite

show abstract

“…This method has been used to estimate use patterns for drugs of abuse in continental Europe (Zuccato et al, 2005;Castiglioni et al, 2006;Mari et al, 2009;Postigo et al, 2010), in Wales (KasprzykHordern et al, 2009) and in Ireland (Bones et al, 2007). Recently, the concentrations of illicit drugs were determined in wastewater from municipal wastewater treatment plants (WWTPs) in the USA (Chiaia et al, 2008;Bartelt-Hunt et al, 2009;Loganathan et al, 2009), although these studies did not include estimates of community drug consumption. To date, no comparable data on the concentrations of illicit drugs in wastewater have been generated for Canadian municipalities.…”

Section: Introductionmentioning

confidence: 99%

Illicit drugs in Canadian municipal wastewater and estimates of community drug use

Metcalfe

Tindale

et al. 2010

Environmental Pollution

184

103

View full text Add to dashboard Cite

show abstract

“…In recent years, however, their occurrence in the environment has raised concerns, both nationally and internationally, regarding implied risks posed to aquatic and terrestrial life forms, including humans [2][3][4][5][6][7]. In the United States (U.S.), pharmaceuticals have been found to occur throughout the water environment [8][9][10][11][12][13], including the drinking water supply [14][15][16][17][18]. Whereas the perceived and actual risks of trace levels of pharmaceuticals in drinking water is a topic of ongoing discussion, this review concentrates on the sources and pathways of water contamination in the U.S. to assess our understanding of the occurrence of pharmaceuticals in U.S. drinking water, and to identify opportunities for pollution control.…”

Section: Introductionmentioning

confidence: 99%

Pharmaceuticals in the Built and Natural Water Environment of the United States

Deo

Halden

2013

Water

View full text Add to dashboard Cite

Abstract:The known occurrence of pharmaceuticals in the built and natural water environment, including in drinking water supplies, continues to raise concerns over inadvertent exposures and associated potential health risks in humans and aquatic organisms. At the same time, the number and concentrations of new and existing pharmaceuticals in the water environment are destined to increase further in the future as a result of increased consumption of pharmaceuticals by a growing and aging population and ongoing measures to decrease per-capita water consumption. This review examines the occurrence and movement of pharmaceuticals in the built and natural water environment, with special emphasis on contamination of the drinking water supply, and opportunities for sustainable pollution control. We surveyed peer-reviewed publications dealing with quantitative measurements of pharmaceuticals in U.S. drinking water, surface water, groundwater, raw and treated wastewater as well as municipal biosolids. Pharmaceuticals have been observed to reenter the built water environment contained in raw drinking water, and they remain detectable in finished drinking water at concentrations in the ng/L to μg/L range.

show abstract

Contamination profiles and mass loadings of macrolide antibiotics and illicit drugs from a small urban wastewater treatment plant

Cited by 149 publications

References 30 publications

Impact of approach used to determine removal levels of drugs of abuse during wastewater treatment

Impact of approach used to determine removal levels of drugs of abuse during wastewater treatment

Illicit drugs in Canadian municipal wastewater and estimates of community drug use

Pharmaceuticals in the Built and Natural Water Environment of the United States

Contact Info

Product

Resources

About